Hub : Traits :

Maternal smoking around birth

23 significantly associated models · 14 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	10	103550604	105282664	3	1	4.0e-11	1.1e-07	0.0302	83	ACTR1A
2	14	103342049	104866687	3	1	4.3e-08	1.7e-06	0.6790	99	KLC1
3	15	78592277	79129823	2	1	7.7e-11	2.6e-12	0.0093	86	CHRNA5
4	16	24614505	25167985	1	1	1.8e-07	7.5e-08	0.0657	88	SLC5A11
5	17	34146026	35644076	3	1	4.7e-08	2.6e-07	0.7500	100	GGNBP2
6	19	18533642	20117685	2	2	3.6e-09	1.5e-06	0.1370	90	SUGP1 TMEM161A

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder or Schizophrenia	6.25	3	2	4.4	0.00	1.00000	ACTR1A CHRNA5 KLC1
Depressed Affect (Nagel 2018)	1.99	2	0	0.0	0.00	1.00000	SLC5A11 SUGP1
Depression (Nagel 2018)	2.53	1	0	0.0	0.00	1.00000	GGNBP2
Intelligence (Savage-Jansen 2018)	4.08	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 SLC5A11
Neuroticism (Nagel 2018)	1.94	2	0	0.0	0.00	1.00000	ACTR1A SUGP1
Schizophrenia (2018)	7.24	3	2	4.4	0.00	1.00000	ACTR1A CHRNA5 KLC1
Worry (Nagel 2018)	2.93	1	1	2.2	0.00	1.00000	ACTR1A
Crohns Disease (2017)	2.00	1	0	0.0	0.00	1.00000	KLC1
Reaction Time	1.62	1	0	0.0	0.00	1.00000	SLC5A11
Verbal and Numeric Reasoning (VNR)	4.53	3	1	2.2	0.00	1.00000	ACTR1A GGNBP2 SLC5A11
Age at First Birth	2.87	1	0	0.0	0.00	1.00000	SUGP1
Body Mass Index (BMI) (2010)	3.57	2	0	0.0	0.00	1.00000	GGNBP2 KLC1
LDL Cholesterol	2.56	1	0	0.0	0.00	1.00000	SUGP1
Neuroticism (2016)	2.52	1	0	0.0	0.00	1.00000	KLC1
Schizophrenia (2014)	6.06	4	2	4.4	0.39	0.61234	ACTR1A CHRNA5 KLC1 SUGP1
Triglycerides	3.18	1	0	0.0	0.00	1.00000	SUGP1
Blood Eosinophil Count	1.17	4	0	0.0	0.34	0.65800	GGNBP2 KLC1 SUGP1 TMEM161A
Blood Platelet Count	1.58	3	2	4.4	0.00	1.00000	KLC1 SUGP1 TMEM161A
Blood Red Count	0.46	1	0	0.0	0.00	1.00000	KLC1
Blood White Count	1.76	3	2	4.4	0.00	1.00000	ACTR1A SLC5A11 TMEM161A
Heel T-Score	5.88	4	1	2.2	0.65	0.35221	ACTR1A KLC1 SLC5A11 SUGP1
BMI	4.91	5	3	6.7	0.94	0.01577	ACTR1A GGNBP2 KLC1 SLC5A11 SUGP1
Height	1.73	6	3	6.7	-0.47	0.34791	ACTR1A GGNBP2 KLC1 SLC5A11 SUGP1 TMEM161A
Waist Hip Ratio (WHR)	1.57	3	0	0.0	0.00	1.00000	GGNBP2 SLC5A11 SUGP1
Systolic Blood Pressure	3.23	2	1	2.2	0.00	1.00000	ACTR1A SLC5A11
Smoking Status	9.15	3	1	2.2	0.00	1.00000	ACTR1A KLC1 SLC5A11
Allergy or Eczema	2.77	2	0	0.0	0.00	1.00000	CHRNA5 GGNBP2
Cardiovascular Disease	2.28	3	0	0.0	0.00	1.00000	GGNBP2 KLC1 SLC5A11
Hypothyroidism (self reported)	1.66	1	0	0.0	0.00	1.00000	SLC5A11
Type 2 Diabetes (T2D) (2018)	2.61	1	0	0.0	0.00	1.00000	SUGP1
Lung FEV1/FVC ratio	2.70	4	2	4.4	-0.41	0.58976	ACTR1A CHRNA5 KLC1 SLC5A11
Lung FVC	0.81	1	0	0.0	0.00	1.00000	CHRNA5
Neuroticism	1.32	1	0	0.0	0.00	1.00000	ACTR1A
Hair Pigment	0.45	1	1	2.2	0.00	1.00000	KLC1
Hand grip strength (left)	4.49	2	1	2.2	0.00	1.00000	ACTR1A SLC5A11
Number of treatments/medications taken	2.93	2	0	0.0	0.00	1.00000	GGNBP2 SUGP1
Sensitivity / hurt feelings	1.63	1	0	0.0	0.00	1.00000	SUGP1
Systolic blood pressure, automated reading	4.10	1	1	2.2	0.00	1.00000	SLC5A11
Eye problems/disorders: Diabetes related eye disease	1.77	1	0	0.0	0.00	1.00000	ACTR1A
Vitamin and mineral supplements	2.81	1	0	0.0	0.00	1.00000	ACTR1A
Severe depression (siblings)	1.89	1	0	0.0	0.00	1.00000	SLC5A11
Pack years adult smoking proportion	28.64	4	1	2.2	0.76	0.23884	CHRNA5 GGNBP2 KLC1 SLC5A11
Impedance of leg (right)	2.85	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 KLC1
Leg fat-free mass (left)	3.07	4	2	4.4	0.98	0.01628	ACTR1A GGNBP2 KLC1 SLC5A11
Trunk fat percentage	3.46	3	2	4.4	0.00	1.00000	GGNBP2 KLC1 SLC5A11
Hand grip strength (right)	4.20	2	2	4.4	0.00	1.00000	ACTR1A SLC5A11
Townsend deprivation index at recruitment	2.47	1	0	0.0	0.00	1.00000	ACTR1A
Current tobacco smoking	8.47	5	1	2.2	0.99	0.00044	ACTR1A CHRNA5 KLC1 SLC5A11 SUGP1
Average weekly fortified wine intake	3.15	1	0	0.0	0.00	1.00000	SLC5A11
Fed-up feelings	2.28	1	0	0.0	0.00	1.00000	SLC5A11
Taking other prescription medications	3.16	2	0	0.0	0.00	1.00000	SLC5A11 SUGP1
Heel bone mineral density (BMD) T-score, automated (left)	4.62	2	1	2.2	0.00	1.00000	KLC1 SLC5A11
High blood pressure	2.63	2	0	0.0	0.00	1.00000	KLC1 SLC5A11
Hayfever, allergic rhinitis or eczema	2.73	2	0	0.0	0.00	1.00000	GGNBP2 SUGP1
Sitting height	0.52	1	0	0.0	0.00	1.00000	SUGP1
Chronic bronchitis/emphysema (father)	4.88	1	1	2.2	0.00	1.00000	CHRNA5
High blood pressure (mother)	1.79	1	0	0.0	0.00	1.00000	GGNBP2
Body mass index (BMI)	5.38	5	3	6.7	0.96	0.00921	ACTR1A GGNBP2 KLC1 SLC5A11 SUGP1
Impedance of leg (left)	2.72	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 KLC1
Leg predicted mass (left)	3.05	4	2	4.4	0.98	0.01739	ACTR1A GGNBP2 KLC1 SLC5A11
Trunk fat mass	4.09	4	2	4.4	0.87	0.12635	ACTR1A GGNBP2 KLC1 SLC5A11
Waist circumference	5.36	4	2	4.4	0.91	0.09395	ACTR1A GGNBP2 KLC1 SLC5A11
Past tobacco smoking	5.63	2	1	2.2	0.00	1.00000	ACTR1A KLC1
Alcohol usually taken with meals	3.41	1	0	0.0	0.00	1.00000	ACTR1A
Nervous feelings	3.72	2	1	2.2	0.00	1.00000	ACTR1A KLC1
Hearing difficulty/problems with background noise	1.99	1	0	0.0	0.00	1.00000	KLC1
Forced vital capacity (FVC)	1.88	1	0	0.0	0.00	1.00000	CHRNA5
Heel bone mineral density (BMD) T-score, automated (right)	3.71	2	1	2.2	0.00	1.00000	KLC1 SLC5A11
Qualifications: None of the above	5.87	4	1	2.2	0.98	0.01549	ACTR1A GGNBP2 SLC5A11 SUGP1
Financial difficulties in last 2 years	2.72	1	0	0.0	0.00	1.00000	KLC1
Mouth/teeth dental problems	4.49	2	0	0.0	0.00	1.00000	CHRNA5 KLC1
Fluid intelligence score	3.88	2	0	0.0	0.00	1.00000	GGNBP2 SLC5A11
Illnesses of siblings	4.60	2	0	0.0	0.00	1.00000	SLC5A11 SUGP1
Weight	4.13	4	3	6.7	0.95	0.04860	ACTR1A GGNBP2 KLC1 SLC5A11
Impedance of arm (right)	3.43	4	1	2.2	-0.99	0.00863	ACTR1A GGNBP2 KLC1 SUGP1
Arm fat percentage (right)	3.90	3	3	6.7	0.00	1.00000	GGNBP2 KLC1 SLC5A11
Trunk fat-free mass	2.16	2	2	4.4	0.00	1.00000	ACTR1A SLC5A11
Hip circumference	2.57	4	0	0.0	1.00	0.00319	ACTR1A GGNBP2 KLC1 SLC5A11
Father's age at death	6.64	1	1	2.2	0.00	1.00000	CHRNA5
Worrier / anxious feelings	3.74	1	1	2.2	0.00	1.00000	ACTR1A
Frequency of tiredness / lethargy in last 2 weeks	2.73	1	0	0.0	0.00	1.00000	SUGP1
Number of live births	3.50	1	0	0.0	0.00	1.00000	SUGP1
Forced expiratory volume in 1-second (FEV1)	2.68	2	1	2.2	0.00	1.00000	ACTR1A CHRNA5
Noisy workplace	3.29	1	0	0.0	0.00	1.00000	SLC5A11
Qualifications: A levels/AS levels or equivalent	4.89	3	0	0.0	0.00	1.00000	ACTR1A SLC5A11 SUGP1
Mouth/teeth dental problems: Dentures	5.45	4	0	0.0	0.98	0.01699	ACTR1A CHRNA5 KLC1 SLC5A11
Lung cancer (father)	7.63	1	1	2.2	0.00	1.00000	CHRNA5
Illnesses of mother	2.86	1	0	0.0	0.00	1.00000	GGNBP2
Forced expiratory volume in 1-second (FEV1), Best measure	2.27	1	1	2.2	0.00	1.00000	CHRNA5
Impedance of arm (left)	3.54	4	1	2.2	-0.99	0.01036	ACTR1A GGNBP2 KLC1 SUGP1
Arm fat mass (right)	4.67	4	3	6.7	0.93	0.06672	ACTR1A GGNBP2 KLC1 SLC5A11
Trunk predicted mass	2.17	2	2	4.4	0.00	1.00000	ACTR1A SLC5A11
Standing height	1.50	3	2	4.4	0.00	1.00000	KLC1 SLC5A11 SUGP1
Exposure to tobacco smoke at home	4.81	1	0	0.0	0.00	1.00000	SUGP1
Birth weight of first child	1.86	1	0	0.0	0.00	1.00000	SUGP1
Peak expiratory flow (PEF)	2.48	2	0	0.0	0.00	1.00000	ACTR1A CHRNA5
Qualifications: O levels/GCSEs or equivalent	2.36	1	0	0.0	0.00	1.00000	GGNBP2
Medication: Paracetamol	3.68	2	0	0.0	0.00	1.00000	KLC1 SUGP1
Hypothyroidism/myxoedema (self-reported)	1.98	1	0	0.0	0.00	1.00000	SLC5A11
Birth weight	2.20	1	0	0.0	0.00	1.00000	SUGP1
Chronic bronchitis/emphysema (mother)	6.02	1	1	2.2	0.00	1.00000	CHRNA5
High blood pressure (siblings)	3.00	2	0	0.0	0.00	1.00000	KLC1 SLC5A11
Forced vital capacity (FVC), Best measure	1.54	2	0	0.0	0.00	1.00000	CHRNA5 SUGP1
Body fat percentage	3.92	3	2	4.4	0.00	1.00000	GGNBP2 KLC1 SLC5A11
Leg fat percentage (right)	4.80	3	3	6.7	0.00	1.00000	GGNBP2 SLC5A11 SUGP1
Arm fat-free mass (right)	2.88	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 SLC5A11
Exposure to tobacco smoke outside home	3.63	2	0	0.0	0.00	1.00000	ACTR1A SLC5A11
Comparative body size at age 10	2.69	1	1	2.2	0.00	1.00000	GGNBP2
Worry too long after embarrassment	1.20	1	0	0.0	0.00	1.00000	ACTR1A
Wheeze or whistling in the chest in last year	3.23	1	0	0.0	0.00	1.00000	KLC1
Age at first live birth	5.40	3	1	2.2	0.00	1.00000	SLC5A11 SUGP1 TMEM161A
Qualifications: College or University degree	4.79	4	1	2.2	-0.99	0.00591	ACTR1A GGNBP2 SLC5A11 SUGP1
Mouth/teeth dental problems: Loose teeth	3.58	2	0	0.0	0.00	1.00000	CHRNA5 SLC5A11
Emphysema/chronic bronchitis	4.01	2	0	0.0	0.00	1.00000	CHRNA5 KLC1
Medication for pain relief, constipation, heartburn	2.68	1	0	0.0	0.00	1.00000	SUGP1
Medication: Blood pressure	2.05	1	0	0.0	0.00	1.00000	SLC5A11
Mean time to correctly identify matches	1.77	1	0	0.0	0.00	1.00000	SLC5A11
Heart disease (mother)	2.02	1	0	0.0	0.00	1.00000	CHRNA5
Whole body fat mass	4.62	4	2	4.4	0.90	0.10146	ACTR1A GGNBP2 KLC1 SLC5A11
Leg fat mass (right)	5.49	5	2	4.4	0.96	0.00799	ACTR1A GGNBP2 KLC1 SLC5A11 SUGP1
Arm predicted mass (right)	3.02	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 SLC5A11
Pulse rate, automated reading	1.44	2	0	0.0	0.00	1.00000	KLC1 SLC5A11
Alcohol intake frequency.	2.29	2	0	0.0	0.00	1.00000	CHRNA5 SLC5A11
Comparative height size at age 10	1.48	3	0	0.0	0.00	1.00000	KLC1 SLC5A11 SUGP1
Suffer from 'nerves'	2.13	1	0	0.0	0.00	1.00000	ACTR1A
Overall health rating	5.71	4	1	2.2	0.98	0.02429	CHRNA5 KLC1 SLC5A11 SUGP1
Chest pain or discomfort	2.88	1	0	0.0	0.00	1.00000	SUGP1
Age at last live birth	3.37	2	0	0.0	0.00	1.00000	SLC5A11 SUGP1
Qualifications: NVQ or HND or HNC or equivalent	2.80	1	0	0.0	0.00	1.00000	ACTR1A
Knee pain experienced in last month	3.05	1	0	0.0	0.00	1.00000	ACTR1A
Hypertension (Self-reported)	2.72	2	0	0.0	0.00	1.00000	KLC1 SLC5A11
Illnesses of siblings: Diabetes	1.87	1	0	0.0	0.00	1.00000	SUGP1
Smoking status: Previous	3.32	1	0	0.0	0.00	1.00000	ACTR1A
Whole body fat-free mass	2.54	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 SLC5A11
Leg fat-free mass (right)	2.86	4	2	4.4	0.98	0.02065	ACTR1A GGNBP2 KLC1 SLC5A11
Arm fat percentage (left)	3.75	3	2	4.4	0.00	1.00000	GGNBP2 KLC1 SLC5A11
Average weekly red wine intake	3.02	1	0	0.0	0.00	1.00000	SLC5A11
Mood swings	2.30	1	0	0.0	0.00	1.00000	SLC5A11
Friendships satisfaction	2.90	1	0	0.0	0.00	1.00000	ACTR1A
Qualifications: nursing, teaching	3.02	1	0	0.0	0.00	1.00000	ACTR1A
Medication for cholesterol	2.42	1	0	0.0	0.00	1.00000	GGNBP2
Mineral and other dietary supplements	3.07	1	0	0.0	0.00	1.00000	ACTR1A
Medication: Gliclazide	1.71	1	0	0.0	0.00	1.00000	SUGP1
Smoking status: Current	7.58	4	1	2.2	1.00	0.00321	ACTR1A KLC1 SLC5A11 SUGP1
Forced expiratory volume in 1-second (FEV1), predicted percentage	2.94	1	1	2.2	0.00	1.00000	CHRNA5
Whole body water mass	2.60	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 SLC5A11
Leg predicted mass (right)	2.89	4	2	4.4	0.98	0.01909	ACTR1A GGNBP2 KLC1 SLC5A11
Arm fat mass (left)	4.75	4	2	4.4	0.94	0.05824	ACTR1A GGNBP2 KLC1 SLC5A11
Number of self-reported non-cancer illnesses	1.85	1	0	0.0	0.00	1.00000	KLC1
Average weekly champagne plus white wine intake	3.07	1	0	0.0	0.00	1.00000	CHRNA5
Miserableness	2.17	1	0	0.0	0.00	1.00000	SLC5A11
Mother's age at death	4.27	1	0	0.0	0.00	1.00000	CHRNA5
High cholesterol (Self-reported)	2.16	1	0	0.0	0.00	1.00000	SUGP1
Medication: Paracetamol	2.55	1	0	0.0	0.00	1.00000	SUGP1
Ever smoked	5.38	2	1	2.2	0.00	1.00000	ACTR1A CHRNA5
Basal metabolic rate	2.98	4	2	4.4	0.97	0.02968	ACTR1A GGNBP2 KLC1 SLC5A11
Leg fat percentage (left)	4.94	4	3	6.7	0.99	0.00563	GGNBP2 KLC1 SLC5A11 SUGP1
Arm fat-free mass (left)	3.06	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 SLC5A11
Risk taking	4.46	2	0	0.0	0.00	1.00000	CHRNA5 KLC1
Diastolic blood pressure, automated reading	3.80	4	1	2.2	0.99	0.01190	GGNBP2 KLC1 SLC5A11 SUGP1
Unable to work because of sickness or disability	6.48	3	0	0.0	0.00	1.00000	CHRNA5 SLC5A11 SUGP1
Vascular/heart problems diagnosed by doctor	3.08	2	1	2.2	0.00	1.00000	KLC1 SLC5A11
Pack years of smoking	26.02	2	1	2.2	0.00	1.00000	CHRNA5 KLC1
Impedance of whole body	3.08	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 KLC1
Leg fat mass (left)	5.52	5	2	4.4	0.96	0.01026	ACTR1A GGNBP2 KLC1 SLC5A11 SUGP1
Arm predicted mass (left)	3.12	3	2	4.4	0.00	1.00000	ACTR1A GGNBP2 SLC5A11

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	1	0.029	1.5
GTEx	Adipose Visceral Omentum	0	0.000	1.5
GTEx	Adrenal Gland	0	0.000	1.3
GTEx	Artery Aorta	1	0.034	1.5
GTEx	Artery Coronary	1	0.085	1.4
GTEx	Artery Tibial	0	0.000	1.5
GTEx	Brain Caudate basal ganglia	0	0.000	1.5
GTEx	Brain Cerebellar Hemisphere	0	0.000	1.4
GTEx	Brain Cerebellum	0	0.000	1.5
GTEx	Brain Cortex	0	0.000	1.6
GTEx	Brain Frontal Cortex BA9	0	0.000	1.5
GTEx	Brain Hippocampus	0	0.000	1.3
GTEx	Brain Hypothalamus	0	0.000	1.3
GTEx	Brain Nucleus accumbens basal ganglia	0	0.000	1.5
GTEx	Brain Putamen basal ganglia	0	0.000	1.4
GTEx	Breast Mammary Tissue	1	0.051	1.5
GTEx	Breast Mammary Tissue (Male)	0	0.000	1.4
GTEx	Breast Mammary Tissue (Female)	0	0.000	1.3
GTEx	Cells EBV-transformed lymphocytes	1	0.070	1.5
GTEx	Cells Transformed fibroblasts	0	0.000	1.4
GTEx	Colon Sigmoid	0	0.000	1.3
GTEx	Colon Transverse	0	0.000	1.4
GTEx	Esophagus Gastroesophageal Junction	0	0.000	1.5
GTEx	Esophagus Mucosa	0	0.000	1.5
GTEx	Esophagus Muscularis	0	0.000	1.5
GTEx	Heart Atrial Appendage	1	0.063	1.4
GTEx	Heart Left Ventricle	0	0.000	1.4
GTEx	Liver	1	0.139	1.3
GTEx	Lung	1	0.035	1.5
GTEx	Muscle Skeletal	2	0.069	1.5
GTEx	Nerve Tibial	0	0.000	1.5
GTEx	Ovary	0	0.000	1.3
GTEx	Pancreas	0	0.000	1.5
GTEx	Pituitary	0	0.000	1.4
GTEx	Prostate	0	0.000	1.5
GTEx	Skin Not Sun Exposed Suprapubic	0	0.000	1.5
GTEx	Skin Sun Exposed Lower leg	1	0.027	1.5
GTEx	Small Intestine Terminal Ileum	0	0.000	1.5
GTEx	Spleen	0	0.000	1.5
GTEx	Stomach	0	0.000	1.4
GTEx	Testis	0	0.000	1.4
GTEx	Thyroid	0	0.000	1.5
GTEx	Uterus	0	0.000	1.4
GTEx	Vagina	0	0.000	1.3
GTEx	Whole Blood	0	0.000	1.4
METSIM	Adipose	1	0.022	1.5
NTR	Blood	0	0.000	1.5
ROSMAP	Brain Pre-frontal Cortex	1	0.023	1.5
YFS	Blood	1	0.022	1.4
CommonMind	Brain Pre-frontal Cortex	0	0.000	1.5
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	1	0.060	1.4
The Cancer Genome Atlas	Breast Invasive Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Colon Adenocarcinoma	1	0.048	1.5
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Glioblastoma Multiforme	0	0.000	1.5
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Brain Lower Grade Glioma	1	0.023	1.4
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	1	0.090	1.5
The Cancer Genome Atlas	Lung Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	1	0.040	1.4
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	1	0.063	1.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	1	0.060	1.5
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	1	0.075	1.4
The Cancer Genome Atlas	Prostate Adenocarcinoma	1	0.022	1.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	0	0.000	1.5
The Cancer Genome Atlas	Soft Tissue Sarcoma	0	0.000	1.4
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.6
The Cancer Genome Atlas	Stomach Adenocarcinoma	0	0.000	1.5
The Cancer Genome Atlas	Testicular Germ Cell Tumors	0	0.000	1.5
The Cancer Genome Atlas	Thyroid Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.5